TR199902315T2 - Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. - Google Patents
Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�.Info
- Publication number
- TR199902315T2 TR199902315T2 TR1999/02315T TR9902315T TR199902315T2 TR 199902315 T2 TR199902315 T2 TR 199902315T2 TR 1999/02315 T TR1999/02315 T TR 1999/02315T TR 9902315 T TR9902315 T TR 9902315T TR 199902315 T2 TR199902315 T2 TR 199902315T2
- Authority
- TR
- Turkey
- Prior art keywords
- quinoline
- carboxylic acid
- antagonist
- excitatory amino
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199902315T2 true TR199902315T2 (xx) | 2000-05-22 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/02315T TR199902315T2 (xx) | 1997-03-26 | 1998-03-24 | Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (zh) |
| JP (1) | JP2001518901A (zh) |
| KR (1) | KR20010005567A (zh) |
| CN (1) | CN1257482A (zh) |
| AP (1) | AP9901659A0 (zh) |
| AU (1) | AU731394B2 (zh) |
| BR (1) | BR9808424A (zh) |
| CA (1) | CA2284710A1 (zh) |
| EA (1) | EA199900755A1 (zh) |
| GB (1) | GB9706294D0 (zh) |
| HU (1) | HUP0001661A3 (zh) |
| ID (1) | ID24306A (zh) |
| IL (1) | IL131919A0 (zh) |
| IS (1) | IS5186A (zh) |
| NO (1) | NO994679L (zh) |
| NZ (1) | NZ337793A (zh) |
| PL (1) | PL335865A1 (zh) |
| TR (1) | TR199902315T2 (zh) |
| WO (1) | WO1998042673A1 (zh) |
| YU (1) | YU47699A (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| JP4754566B2 (ja) * | 2005-07-22 | 2011-08-24 | 持田製薬株式会社 | 新規なヘテロシクリデンアセトアミド誘導体 |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| JP7305560B2 (ja) | 2017-06-12 | 2023-07-10 | グリテック， エルエルシー | Ｎｍｄａアンタゴニスト及びｄ２／５ｈｔ２ａ又は選択的５ｈｔ２ａアンタゴニストによるうつ病の治療 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| KR100464895B1 (ko) * | 1995-09-29 | 2005-05-16 | 글락소 웰컴 에스피에이 | Nmda길항제로서의테트라히드로퀴놀린 |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Application Discontinuation
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010005567A (ko) | 2001-01-15 |
| GB9706294D0 (en) | 1997-05-14 |
| ID24306A (id) | 2000-07-13 |
| JP2001518901A (ja) | 2001-10-16 |
| NO994679L (no) | 1999-11-24 |
| AU7209498A (en) | 1998-10-20 |
| NZ337793A (en) | 2001-02-23 |
| NO994679D0 (no) | 1999-09-24 |
| CN1257482A (zh) | 2000-06-21 |
| AU731394B2 (en) | 2001-03-29 |
| AP9901659A0 (en) | 1999-09-30 |
| EP0971896A1 (en) | 2000-01-19 |
| CA2284710A1 (en) | 1998-10-01 |
| IS5186A (is) | 1999-09-17 |
| PL335865A1 (en) | 2000-05-22 |
| HUP0001661A2 (hu) | 2000-09-28 |
| WO1998042673A1 (en) | 1998-10-01 |
| YU47699A (sh) | 2001-12-26 |
| IL131919A0 (en) | 2001-03-19 |
| EA199900755A1 (ru) | 2000-08-28 |
| BR9808424A (pt) | 2000-05-23 |
| HUP0001661A3 (en) | 2001-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002015T2 (tr) | Protein tirosin kinaz inhibitörleri olarak bisiklik heteroaromatik bileşikler. | |
| CA2473991A1 (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | |
| TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
| DE69802389D1 (de) | Verbindungen verwendbar als effektoren von neuroexcitatorischen aminosäure-empfindlichen rezeptoren des zentralnervensystems, ihre herstellung and ihre biologischen verwendungen | |
| TR200302105T4 (tr) | Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları. | |
| EP0271287A3 (en) | Quinoline dioic acids and amides | |
| TR199902315T2 (xx) | Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. | |
| TR199901949T2 (xx) | Lemfositik t�m�rler i�in �areler. | |
| TR199900486T2 (xx) | Aziniloksi ve fenoksi-diaril-karbonasit t�revleri. | |
| TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
| TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| ATE285772T1 (de) | Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten | |
| TR200001182T2 (tr) | Yeni karbonik asit türevleri, üretimleri ve kullanımları. | |
| ATE414100T1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
| HUP0000882A2 (hu) | NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| TR200000371T2 (tr) | 3-İkame edilen 3,4,5,7,- tetrahidro-pirrolo [3',4':4,5] tieno[2,3-D] pirimidin türevleri, üretimi ve 5HT-antagonistleri olarak kullanımları. | |
| TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
| TR199903159T2 (xx) | Yeni �-Amino ve �-Azido karbonik asit t�revleri. | |
| BR9811954A (pt) | ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias | |
| HUP0002930A2 (hu) | Eljárás 3-ciano-2,4-dihalogén-5-fluor-benzoesavak előállítására, intermedierjeik és ezek előállítása | |
| HUP0202895A2 (hu) | Eljárás késleltetett hatóanyag-leadású komplexek előállítására | |
| TR200001365T2 (tr) | Yeni heterosiklik ikame edilmiş a-hidroksikarbonik asit türevleri | |
| BG106329A (en) | Taste masking of oral quinolone liquid preparations using ion exchange resins |